[Therapy of primary aldosteronism].
D000236:Adenoma / Q000150:complications / Q000175:diagnosis; D000303:Adrenal Cortex Diseases / Q000150:complications / Q000175:diagnosis*; D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000175:diagnosis*; D000315:Adrenalectomy; D002277:Carcinoma / Q000150:complications / Q000175:diagnosis; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006929:Hyperaldosteronism / Q000209:etiology / Q000628:therapy*; D006965:Hyperplasia; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use
D000451:Mineralocorticoid Receptor Antagonists; D006852:Hydrochlorothiazide; D013148:Spironolactone
Therapie des primären Aldosteronismus.